Skip to main content
. Author manuscript; available in PMC: 2016 Aug 23.
Published in final edited form as: Ann Surg. 2015 Mar;261(3):487–496. doi: 10.1097/SLA.0000000000000757

Table 6.

Postoperative Outcomes and Serum anti-TNFα Drug Levels in UC Cohort

UC
Cohort
(n=94)
Undetectable
Level
(n=77)
Detectable
Level
(n=17)
P

Postoperative morbidity 39 (41) 31 (40) 8 (47) 0.61

Medical complications 11 (12) 8 (10) 3 (18) 0.41
  Major 4 (4) 3 (4) 1 (6) 0.72
  Minor 7 (7) 5 (6) 2 (12) 0.46

Surgical complications 29 (31) 24 (31) 5 (29) 1.00
  Major 10 (11) 8 (10) 2 (12) 0.87
  Minor 19 (20) 16 (21) 3 (18) 0.77

Infectious complications 12 (13) 10 (13) 2 (12) 0.89

Mean postoperative LOS (d) 6.3 (2.1) 6.3 (2.1) 6.0 (2.3) 0.54

Readmission within 30 days 19 (20) 15 (19) 4 (23) 0.71

All values in parentheses denote % except postoperative length of stay (standard deviation)

LOS length of stay